
Profile and evolution of the chemosusceptibility of falciparum malaria imported into France in 2000
Author(s) -
Pascal Ralaimazava,
Rémy Durand,
N. Godineau,
A. Keundjian,
Z Jezic,
Bruno Pradines,
Olivier Bouchaud,
J. Le Bras
Publication year - 2002
Publication title -
euro surveillance/eurosurveillance
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.766
H-Index - 104
eISSN - 1560-7917
pISSN - 1025-496X
DOI - 10.2807/esm.07.07.00355-en
Subject(s) - malaria , quinine , mefloquine , plasmodium falciparum , chloroquine , virology , drug resistance , first line , medicine , biology , immunology , microbiology and biotechnology
In 2000, the chemosusceptibility of imported malaria was stable in France. All countries of infection considered, the bi-resistance to chloroquine and cycloguanil has not changed from 1996 to 2000. The monotherapy using quinine or mefloquine remains the first-line treatment to falciparum malaria. Resistance to these two antimalarials is rare in Africa and has not evolved over the past 15 years.